XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   Three months ended June 30,   Six months ended June 30, 
Sale of Product  2021   2020   2021   2020 
Radiochemical Products  $1,228,209   $1,113,053   $1,889,386   $1,868,274 
Cobalt Products   576,994    224,666    695,367    530,286 
Nuclear Medicine Standards   885,728    777,873    2,014,887    1,819,997 
Radiological Services   68,965    43,967    130,755    116,288 
Fluorine Products               22,013    160,500 
Total Segments   2,759,896    2,159,559    4,752,408    4,495,345 
Corporate revenue                         
Total Consolidated  $2,759,896   $2,159,559   $4,752,408   $4,495,345 

 

   Three months ended June 30,   Six months ended June 30, 
Depreciation and Amortization  2021   2020   2021   2020 
Radiochemical Products  $78,430   $10,354   $157,977   $20,708 
Cobalt Products   12,399    8,762    26,038    17,523 
Nuclear Medicine Standards   17,868    15,989    34,238    31,978 
Radiological Services   252    8,519    504    17,155 
Fluorine Products   31,158    30,898    57,253    56,993 
Total Segments   140,107    74,522    276,010    144,357 
Corporate depreciation and amortization   6,941    (349)   11,240    4,433 
Total Consolidated  $147,048   $74,173   $287,250   $148,790 

 

   Three months ended June 30,   Six months ended June 30, 
Segment Income (Loss)  2021   2020   2021   2020 
Radiochemical Products  $404,457   $380,728   $408,882   $386,347 
Cobalt Products   208,581    75,874    178,484    199,670 
Nuclear Medicine Standards   51,843    117,056    262,754    302,357 
Radiological Services   58,242    (13,532)   110,649    (28,461)
Fluorine Products   (31,627)   (36,460)   (65,141)   86,410 
Total Segments   691,496    523,666    895,628    946,323 
Corporate loss   (872,883)   (294,338)   (1,678,167)   (1,139,489)
Net Income (Loss)  $(181,387)  $229,328   $(782,539)  $(193,166)

 

   Three months ended June 30,   Six months ended June 30, 
Expenditures for Segment Assets  2021   2020   2021   2020 
Radiochemical Products  $     $     $3,103   $   
Cobalt Products               16,592       
Nuclear Medicine Standards   32,911          167,911       
Radiological Services                        
Fluorine Products               4,060    1,565 
Total Segments   32,911          191,666    1,565 
Corporate purchases                        
Total Consolidated  $32,911   $     $191,666   $1,565 

 

   June 30,   December 31, 
Segment Assets  2021   2020 
Radiochemical Products  $3,067,625   $2,916,442 
Cobalt Products   632,133    743,127 
Nuclear Medicine Standards   2,235,779    2,052,220 
Radiological Services   15,057    60,696 
Fluorine Products   5,312,164    5,371,506 
Total Segments   11,262,758    11,143,991 
Corporate assets   4,546,988    5,952,758 
Total Consolidated  $15,809,746   $17,096,749